ArticleInternational journal of retina and vitreous2021
Vogt-Koyanagi-Harada Syndrome following COVID-19 and ChAdOx1 nCoV-19 (AZD1222) vaccine.
Article in International journal of retina and vitreous, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 37 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
37 citing papers in PubMed, 63 citations in OpenAlex.
- Seasonal Variations of Vogt-Koyanagi-Harada Disease in Japan: A Study on Long-Term Trends and the Influence of Coronavirus Disease 2019 (COVID-19).Ophthalmology science · 2026Article
- Effect of the COVID-19 pandemic on Vogt-Koyanagi-Harada disease.Scientific reports · 2024Article
- Vogt-Koyanagi-Harada disease after SARS-CoV-2 infection: Case report and literature review.Immunity, inflammation and disease · 2024Review
- Choroiditis following severe acute respiratory syndrome coronavirus 2 infection in unvaccinated identical twins.Arquivos brasileiros de oftalmologia · 2024Article
- Vogt-Koyanagi-Harada Disease and COVID.Journal of clinical medicine · 2023Review
- Ocular manifestations following COVID-19 vaccination.Journal of ophthalmic inflammation and infection · 2023Article
- Challenges in posterior uveitis-tips and tricks for the retina specialist.Journal of ophthalmic inflammation and infection · 2023Review
- Correction.Human vaccines & immunotherapeutics · 2023Article
- Intraocular inflammation following COVID-19 vaccination: the clinical presentations.International ophthalmology · 2023Article
- Clinical features, diagnosis, and management of COVID-19 vaccine-associated Vogt-Koyanagi-Harada disease.Human vaccines & immunotherapeutics · 2023Article
- A COVID-19 perspective of Vogt-Koyanagi-Harada disease.Indian journal of ophthalmology · 2023Article
- A case of APMPPE-like panuveitis presenting with extensive outer retinal layer impairment following COVID-19 vaccination.BMC ophthalmology · 2023Article
- Uveitis including Vogt-Koyanagi-Harada syndrome following inactive covid-19 vaccination: a case series.Journal of ophthalmic inflammation and infection · 2023Article
- Posterior ocular manifestations following BNT162b2 mRNA COVID-19 vaccine: a case series.International ophthalmology · 2023Article
- Vogt-Koyanagi-Harada syndrome in the setting of COVID-19 infection.Clinical case reports · 2023Article
- Vogt-Koyanagi-Harada disease following ChAdOx1 nCoV-19 and mRNA-1273 vaccination.Journal francais d'ophtalmologie · 2023Article
- Questionnaire survey of risk factors for recurrence of ocular inflammation in patients with uveitis after SARS-CoV-2 infection.Frontiers in cellular and infection microbiology · 2023Article
- Case Report: Spectrum of interesting ocular manifestations following COVID-19 vaccination: a case series of real-world presentations.Frontiers in cellular and infection microbiology · 2023Article
- The Characteristics of COVID-19 Vaccine-Associated Uveitis: A Summative Systematic Review.Vaccines · 2022Review
- Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors at 4 institutions in 1 country.
Funding
Abstract
The challenge of COVID-19 has rapidly changed medical management worldwide. The relatively small time from pandemic to vaccines regulatory approval triggered a race toward vaccines development. However, important questions regarding SARS-CoV-2 vaccines remain. A case of complete Vogt-Koyanagi-Harada (VKH) Syndrome that occurred 4 days following SARS-CoV-2 vaccination and another patient that developed VKH 14 days post COVID-19 clinical onset are presented. A causal relationship between COVID-19 and uveitis may exist.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.